KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Other financing activities (2016 - 2025)

Cme (CME) has disclosed Other financing activities for 17 consecutive years, with $100000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other financing activities rose 150.0% to $100000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$8.7 million, a 5.43% increase, with the full-year FY2025 number at -$8.7 million, up 5.43% from a year prior.
  • Other financing activities was $100000.0 for Q4 2025 at Cme, up from -$4.3 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $3.7 million in Q2 2023 to a low of -$8.9 million in Q4 2023.
  • A 5-year average of -$2.0 million and a median of -$1.9 million in 2021 define the central range for Other financing activities.
  • Biggest YoY gain for Other financing activities was 1333.33% in 2023; the steepest drop was 990.0% in 2023.
  • Cme's Other financing activities stood at -$400000.0 in 2021, then surged by 350.0% to $1.0 million in 2022, then plummeted by 990.0% to -$8.9 million in 2023, then soared by 97.75% to -$200000.0 in 2024, then soared by 150.0% to $100000.0 in 2025.
  • Per Business Quant, the three most recent readings for CME's Other financing activities are $100000.0 (Q4 2025), -$4.3 million (Q3 2025), and -$100000.0 (Q2 2025).